Activation of signal transducer and activator of transcription 1 (STAT1) is
a hallmark of IFN-gamma receptor signal transduction but is also part of t
he signalling pathway of other cytokines/growth factor receptors. In ulcera
tive colitis, high levels of activation and expression of STAT1 have been o
bserved in comparison with both Crohn's Disease and normal controls. Pouchi
tis develops in some patients after Ileal-Pouch-Anal-Anastomosis (IPAA). Th
e pathophysiology and aetiology of pouchitis is still unclear. Recent studi
es have shown an increased production of proinflammatory cytokines includin
g IFN-gamma. To investigate the expression and activation of STAT1 in pouch
itis and the influence of treatment, patients were followed longitudinally
from pouch operation. Diagnosis of pouchitis was made by clinical, endoscop
ic and histological criteria. Biopsies were obtained during routine endosco
py and snap frozen in liquid nitrogen. Nuclear and cytosolic extracts were
prepared and the expression and activation of specific transcription factor
s were assessed by Western blot, electrophoretic mobility shift assay and i
mmunofluorescence. Patients who develop pouchitis show highly increased lev
els of STAT1 alpha as well as STAT1 beta expression and activation in compa
rison with both normal pouch and normal ileal mucosa. Improvement of pouchi
tis during antibiotic therapy relates to a normalization of STAT1 expressio
n and activation. We conclude that activation of STAT1 correlates to clinic
al disease activity and therefore STAT1 could play an important role in the
pathophysiology of pouchitis. Similarities in the pattern of activation of
STAT1 in pouchitis and ulcerative colitis may suggest a common pathway in
the immunopathophysiology of both diseases.